AbbVie (DE:4AB)
XETRA:4AB
Holding DE:4AB?
Track your performance easily

AbbVie (4AB) Technical Analysis

17 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is 3.56, suggesting AbbVie is a Sell.
AbbVie’s (4AB) 20-Day exponential moving average is 181.55, while AbbVie’s (4AB) share price is €187.56, making it a Buy.
AbbVie’s (4AB) 50-Day exponential moving average is 176.98, while AbbVie’s (4AB) share price is €187.56, making it a Buy.

AbbVie (4AB) Pivot Points

Nov 10, 2024, 03:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
179.98
182.34
184.14
186.50
188.30
190.66
192.46
Fibonacci
182.34
183.93
184.91
186.50
188.09
189.07
190.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Nov 10, 2024, 03:00 AM
Period
Simple
Exponential
MA5
187.09Buy
186.90Buy
MA10
184.48Buy
184.71Buy
MA20
179.75Buy
181.55Buy
MA50
176.65Buy
176.98Buy
MA100
170.56Buy
171.16Buy
MA200
162.24Buy
161.92Buy
AbbVie’s (4AB) 10-Day exponential moving average is 184.71, while AbbVie’s (4AB) share price is €187.56, making it a Buy.
AbbVie’s (4AB) 100-Day exponential moving average is 171.16, while AbbVie’s (4AB) share price is €187.56, making it a Buy.
AbbVie’s (4AB) stock price is €187.56 and AbbVie’s (4AB) 50-day simple moving average is 176.65, creating a Buy signal.
AbbVie’s (4AB) stock price is €187.56 and AbbVie’s (4AB) 100-day simple moving average is 170.56, creating a Buy signal.
AbbVie’s (4AB) stock price is €187.56 and AbbVie’s (4AB) 200-day simple moving average is 162.24, creating a Buy signal.

AbbVie (4AB) Technical Indicators

Nov 10, 2024, 03:00 AM
Name
Value
Implied Action
RSI (14)
61.81
Neutral
STOCH (9,6)
79.26
Neutral
STOCHRSI (14)
81.19
Sell
MACD (12,26)
3.56
Sell
ADX (14)
22.67
Neutral
Williams %R
-24.24
Buy
CCI (14)
93.15
Neutral
ATR (14)
3.57
-
Ultimate Oscillator
58.12
Neutral
ROC
8.72
Buy
AbbVie’s (4AB) Relative Strength Index (RSI) is 61.81, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 22.67, creating a Neutral signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is 93.15, creating a Neutral signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is 8.72, creating a Buy signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Strong Buy.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 61.81, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is 3.56, which suggests 4AB is a Sell.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 187.09, which suggests 4AB is a Buy.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 179.75, which suggests 4AB is a Buy.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 176.65, which suggests 4AB is a Buy.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 162.24, which suggests 4AB is a Buy.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -24.24, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is 93.15, which suggests 4AB is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis